Bill
HD 2114
Overview: HD 2114, An Act relative to increased availability of opioid antagonist medication, proposed bill, introduced November 29, 2025.Purpose and Intent: The goal of this legis
Overview: HD 2114, An Act relative to increased availability of opioid antagonist medication, proposed bill, introduced November 29, 2025.
Purpose and Intent: The goal of this legislation is to improve access to opioid antagonist medications, such as naloxone, in order to reduce opioid overdose deaths in Massachusetts. Opioid antagonists can quickly reverse the effects of an opioid overdose, but their availability and use has been limited. This bill seeks to expand access and utilization of these life-saving drugs.
Key Provisions:
- Requires all pharmacies in the state to stock and dispense opioid antagonist medications without a prescription.
- Provides liability protections for healthcare providers who prescribe or dispense opioid antagonists.
- Mandates insurance coverage for opioid antagonist medications with no cost-sharing for patients.
- Establishes an educational campaign to raise awareness about opioid overdose recognition and response.
Affected Parties and Impacts: This bill would primarily benefit individuals at risk of opioid overdose, as well as their family members and communities. By increasing the availability and affordability of opioid antagonists, the legislation aims to empower more people to intervene and save lives during an overdose emergency. Pharmacies, healthcare providers, and insurers would also be impacted by the new requirements.
Procedural and Timeline Considerations: The bill has been introduced in the state legislature and is currently under consideration. If passed, the new laws would likely take effect within 6-12 months to allow time for implementation by the relevant state agencies and stakeholders.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
